-
Small caps lead losses amid US-China tensions revival
-
Inflation expectation cold down in May, PCE drops marginally
-
Gap shares sell off on tariff costs
Wall Street sees a new wave of risk-off sentiment, as Donald Trump reignited US-China tensions with his latest social media statement that “China has totally violated its agreement with us.” The president’s accusation comes amid stalled trade talks and fresh concerns over China’s compliance, particularly regarding critical minerals and rare earth magnets. This marks a setback after the recent tariff easing agreement reached in Switzerland, which had briefly lifted investor hopes for a trade détente.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appMeanwhile, the US administration continues to tighten restrictions, including revoking some Chinese student visas and limiting technology exports, further straining relations. With no recent high-level communication between Trump and Chinese President Xi Jinping, market uncertainty intensifies as investors grapple with the potential fallout of escalating geopolitical friction and its impact on global economic growth.
In consequence, Friday’s opening has been defined by losses on major US indices, albeit the better-than-expected University of Michigan report helped to narrow today’s gap. Russell 2000 slides the most (-0,4%), S&P 500 and Nasdaq are flat, while Dow Jones trades slightly in the green (+0,1%)
Macro update
US inflation data showed a slight easing, with headline inflation coming in below expectations and core inflation dipping minimally (2.5% from 2.6%) but still above the Fed’s target. Despite strong income growth, consumer spending slowed, reflecting cautious behavior. Tariffs may keep PCE inflation elevated, potentially limiting consumption’s contribution to GDP growth in months to come.
The University of Michigan Consumer Sentiment Index rose slightly to 52.2 in May’s second reading, steady from April. Year-ahead inflation expectations eased to 6.6%, and the five-year outlook dropped to 4.2%, the first decline since December 2024. Improvements in current conditions and expectations followed a temporary tariff pause on Chinese goods, helping ease consumer worries.
US100 (D1 interval)
The Nasdaq 100 has once again pulled back after hitting resistance near the 21,530 level, highlighting the market’s struggle to push the tech-heavy index toward its all-time highs amid ongoing tariff uncertainties affecting global tech companies. A mix of mostly positive macro data and aggressive tariff concerns has kept the index confined to a tight range as the week closes. The US100 remains just below overbought territory, leaving room for a potential pullback toward the 20,500 level if tariff issues start to outweigh the recent strong earnings from major tech firms.
Source: xStation5
Company news:
-
American Eagle (AEO.US ) is down 1% after the company missed Q2 operating income estimates and forecasted weaker sales, driven by higher discounts amid assortment misses and inventory write-downs. Management withdrew its full-year outlook due to macro uncertainty but plans $275 million in 2025 capital expenditures.
-
Cooper Cos (COO.US) plunges nearly 15% after the company lowered its organic growth outlook for FY25 despite beating Q2 earnings and revenue estimates. JPMorgan downgraded the stock, citing mixed execution and a slower market recovery, while other analysts view guidance as conservative but highlight solid fundamentals and strong growth in daily silicone hydrogel lenses and surgical segments.
-
Gap (GAP.US) slumps 20% after warning of a $250–$300M tariff hit and ongoing weakness at Banana Republic and Athleta. Despite strength at Old Navy and Gap, investor sentiment soured due to trade headwinds and slow brand turnarounds. Guidance excludes potential tariff costs, adding near-term uncertainty. While management is executing a brand refresh and reporting solid core performance, external pressures and soft discretionary demand may weigh on momentum.
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.